Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Mirlohi MS, Ekrami A, Shirali S, Ghobeishavi M, Pourmotahari F (2016) Hematological and liver toxicity of anti-tuberculosis drugs. Electron Phys 8(9):3005–3010PubMedPubMedCentralCrossRef
2.
Dosi R, Chandelkar A, Jain A, Motiwale S, Joshi P, Jain P (2019) Rifampicin-induced thrombocytopenia: a rare complication. J Assoc Chest Phys 7:38–40CrossRef
3.
Choong K, Looke D (2011) Cross-reaction to rifabutin after rifampicin induced flu-like syndrome and thrombocytopenia. Scand J Infect Dis 43(3):238PubMedCrossRef
4.
5.
Gupta R, Wargo KA (2005) Rifampin-induced thrombotic thrombocytopenic purpura. Ann Pharmacother 39(10):1761–1762PubMedCrossRef
6.
7.
Dhibar DP, Sahu KK, Dhir V, Singh S. Immune Thrombocytopenia as a Presenting Manifestation of Tuberculosis- Challenge in Resource Constraint Settings. J Clin Diagn Res. 2016 10(10): OD01-OD02.
8.
Sahu KK, Varma SC (2016) Cortical vein thrombosis in a case of idiopathic thrombocytopenic purpura. Platelets 26(4):374–375CrossRef
9.
Metadata
Title
Rifampin Induced Thrombotic Thrombocytopenic Purpura
Authors
Hannah Hamad
Kamal Kant Sahu
Steven Dunn
Lucia Milla
Alice Caffery
Nahida Islam
Publication date
01-07-2020
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01249-9

Other articles of this Issue 3/2020

Indian Journal of Hematology and Blood Transfusion 3/2020 Go to the issue

Original Article

Impact of World Health Organization (WHO) Revised Criteria-2016 on the Diagnosis of Polycythemia Vera

Original Article

FLAER Based Assay According to Newer Guidelines Increases Sensitivity of PNH Clone Detection

Correspondence

Algorithm to Study HLA-Antibodies and Selecting Criteria for the Best Haploidentical Donor

Review Article

Re-defining Prognosis of Hematological Malignancies by Dynamic Response Assessment Methods: Lessons Learnt in Chronic Myeloid Leukemia, Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma and Multiple Myeloma

Images

Acute Coronary Syndrome Associated with Carfilzomib Treatment

Short Communication

Peripheral Blood and Bone Marrow Findings in Chronic Alcoholics with Special Reference to Acquired Sideroblastic Anemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits